B[Li Qiang and Russian Prime Minister Mishustin co-chaired the 31st regular meeting between the prime ministers of China and Russia] On the morning of October 21, Premier Li Qiang of the State Council co-chaired the 31st regular meeting between the prime ministers of China and Russia with Russian Prime Minister Mishustin in St. Petersburg.
Li Qiang said that in recent years, faced with the complex and turbulent international situation, China and Russia, under the strategic guidance of the two heads of state, have worked hand in hand and moved forward in unity, using dynamic and resilient cooperation to offset the instability and uncertainty of the external environment. The road to cooperation has become wider and wider, and the pace has become increasingly stable. At present, the China-Russia comprehensive strategic partnership of coordination for a new era is entering a new stage of more promising and faster development. China is willing to work with Russia to carry forward the spirit of mutual respect, mutual benefit and win-win results, promote deeper and more practical cooperation in all fields, and better translate the important consensus reached by the two heads of state into practical actions and concrete results, so as to better serve the development and revitalization of the two countries and benefit more people of the two countries.
Mishustin said that this year marks the 25th anniversary of the signing of the Russia-China Treaty of Good-Neighborliness, Friendship and Cooperation. Currently, the Russia-China comprehensive strategic partnership of coordination for a new era is at an all-time high, setting a model for inter-state relations. Facing the uncertainty of the international situation, the economic and trade cooperation between the two countries has a good momentum. Russia is willing to work with China to further strengthen practical cooperation in various fields and safeguard the common interests of the two countries on the basis of mutual benefit, mutual respect, and good-neighborliness.
Li Qiang and Mishustin listened to reports from representatives of both sides on the work of the China-Russia Investment Cooperation Committee, the China-Russia Energy Cooperation Committee, the China-Russia Humanities Cooperation Committee, the China-Russia Prime Ministers Regular Meeting Committee, and the Intergovernmental Cooperation Committee for Northeast China and the Russian Far East.
The two Prime Ministers fully recognized the work of each committee in the past year. Both sides agreed that the directional leadership of the heads of state is an important guarantee for the steady development of China-Russia relations. They should follow the important consensus of the two heads of state as a fundamental basis, promote cooperation in key areas such as economic and trade investment, energy resources, interconnection, aerospace, finance, industry, etc., cultivate new momentum for the development of cutting-edge fields such as artificial intelligence, biotechnology, and digital economy, jointly hold the "China-Russia Education Year", strengthen cultural exchanges in tourism, culture, youth, media, etc., stimulate the vitality of local cooperation, intensify communication and collaboration on multilateral affairs, and promote the achievement of more practical results.
After the meeting, the two prime ministers signed the "Joint Communique of the 31st Regular Meeting between the Prime Ministers of China and Russia". The two sides also reached cooperation documents in the fields of economy and trade, aerospace, science and technology, education and other fields.
Wu Zhenglong participated in the above activities. (Xinhua News Agency) B[What are the main considerations for the biomedical technologies to be added? Ministry of Commerce's response] On October 16, the spokesperson of the Ministry of Commerce answered reporters' questions on the revision of the "China's Catalog of Export Prohibited and Restricted Technologies". Q: What are the main considerations for the biomedical technologies to be added?
Answer: There are already some biomedical technologies in the current "Catalogue". This time, it is planned to add 5 technologies related to pathogenic microorganisms, cell and gene therapy, and small nucleic acid drugs. The main considerations are as follows:
The first is to safeguard human life, health and safety. Pathogenic microbial technologies are directly related to human health and national biosecurity. Including them in the Catalog and prohibiting their export is an institutional arrangement to safeguard national security and build a biosecurity barrier. It is also an objective need to protect the health of all mankind.
The second is to support China’s biomedical technology to carry out international cooperation in an orderly manner in accordance with laws and regulations. The listing of biomedical technologies this time will exclude or apply convenient measures to important situations of international cooperation. For example, export situations such as external authorization and licensing of relevant technology and process platforms with independent intellectual property rights, and use of relevant technology and processes to provide outsourced R&D and production services are not included in the scope of management; for relevant target discovery and verification technologies with independent intellectual property rights, exports through external authorization and licensing will be subject to convenient measures such as automatic licensing.
The third is to implement the concept of a human health community. This policy clearly stipulates that for exports of restricted technologies that are required for public health emergencies, humanitarian relief, use of overseas resources for joint research and development, etc., convenient measures such as automatic licensing are applicable. China will continue to share its technological development achievements with other countries around the world and make positive contributions to improving human health and well-being. B[The Hang Seng Index and Hang Seng Technology Index both rose by about 1%, and pharmaceutical stocks and biotechnology stocks rose] On October 6, Hong Kong stocks closed higher, with the Hang Seng Index rising by 1% and the Hang Seng Technology Index rising by 0.94%. Zhipu rose more than 7%, and GLM-5.3 was listed on Amazon Bedrock. Pharmaceutical stocks and biotechnology stocks rose. CanSino Biologics rose by more than 14%, Biocytogen-B rose by more than 11%, Zai Lab rose by more than 9%, Insilico Intelligent, Sino Biopharmaceuticals, and Kangfang Biologics rose by more than 4%, 3SBio and Chi-Med Pharmaceuticals rose by more than 3%, and Hopewell Pharmaceuticals-B rose by about 3%. B[AI pharmaceutical concept rebounded with shock and Chengdu Pioneer rose by more than 10%] On September 16th, the AI pharmaceutical concept rebounded with shock and rebound in the afternoon, with Chengdu Pioneer rising by more than 10%. Nearshore Protein, Kailer Shares, Medicilon, Hongbo Pharmaceutical, Boji Pharmaceutical, and Yaoshi Technology were among the top gainers. In terms of news, on September 14, the State Council Information Office held a press conference to introduce the decisive progress in promoting the construction of a healthy China. The National Health Commission proposed that attention should be paid to technological empowerment, especially the widespread application of artificial intelligence technology and biotechnology in the health field. B[Guangzhou: Promote the acceleration of the marine pharmaceutical and biological products industry] On September 14th, the General Office of the Guangzhou Municipal People's Government recently issued the "Notice of the "15th Five-Year Plan" for the Development of Guangzhou's Marine Economy". It is proposed to promote the accelerated development of the marine pharmaceutical and biological products industry. Improve the utilization level of deep-sea biological resources and build a biological gene bank and information database of medicinal sources in the South China Sea. Innovate a new paradigm of intelligent development of "AI + marine drugs", tackle core technologies for the extraction and utilization of marine biological resources such as fish oil, fish collagen, chitosan, and seaweed polysaccharides, develop carbohydrate drugs and peptide drugs, and create a "South China Sea Drug Library" with the characteristics of tropical marine biological resources. Vigorously promote the research and development of original marine drugs for diseases such as tumors and cardiovascular diseases, and promote the research and development of marine biomedical materials such as hemostasis and repair. Strengthen sea-related traditional Chinese medicines such as seahorses and seaweeds. Focus on breakthroughs in marine active substance extraction and purification technology, enzyme engineering technology, fermentation technology, etc., and accelerate the productization process of special raw materials such as seabed mud and deep water. Develop new marine foods and new raw materials for health foods, and use modern biotechnology to promote the upgrading of advantageous industries such as marine foods and cosmetics. B[The Ministry of Commerce answers a reporter’s question on a senior CIA official’s public statements about carrying out espionage activities against China] A spokesman for the Ministry of Commerce responded to a reporter’s question on a senior CIA official’s public statements on carrying out espionage activities against China. Reporter asked: Ellis, the deputy director of the US Central Intelligence Agency, recently stated publicly that the US is carrying out broader espionage activities against China, including Chinese companies, to deal with China's "dual threats" in the military and economic fields. In particular, it has listed Chinese companies in artificial intelligence, semiconductors, biotechnology and other fields as legitimate targets for espionage activities. What is China’s comment on this?
A: We have noticed the relevant situation. The United States has nakedly declared that Chinese companies are legitimate targets of espionage activities, completely tearing off the fig leaf that intelligence agencies use to steal secrets behind the scenes, and exposing the hegemonic gangster logic to the sun. China expresses serious concern and firmly opposes this.
The US actions wantonly undermine fair competition. Economic competition is a normal business activity, and the acquisition of leading advantages is the result of relying on technology, talent and innovation. The United States generalizes the concept of national security, blurs the boundaries between competition and security, and even defines economic competition as a so-called "threat." This is essentially the Cold War mentality of zero-sum game. U.S. intelligence agencies have interfered with normal economic competition. Related practices have seriously damaged the business expectations of companies in various countries and undermined the global market environment of fair competition.
The US behavior is typical of saying one thing and doing another. On the one hand, in 2014, the United States issued Presidential Policy Directive No. 28, which clearly stipulates that it is not allowed to collect foreign private business information or trade secrets through intelligence activities for the purpose of helping American companies or businesses gain competitive advantages. In 2022, the United States issued Executive Order No. 14086 to reaffirm the above restrictions. However, the United States ignores its own boundaries. Its intelligence agencies carry out large-scale cyber theft and intelligence theft against countries around the world. It is itself the world's number one habitual espionage offender. Now it is even more openly claiming that as long as it constitutes economic competition, it can be regarded as a legitimate target of espionage activities. This is a blatant violation of international trade rules and intellectual property protection norms. On the other hand, the United States has long accused other trading partners of harming U.S. interests through intelligence theft, but now it characterizes its own espionage as legitimate. This is obviously a typical act of double standards.
The US actions are an attempt to suppress and smear China. The US claims that China is a "double threat" militarily and economically. It is a gangster's rhetoric that confuses right and wrong, and is a malicious slander with ulterior motives. China's technological breakthroughs in the fields of artificial intelligence, semiconductors, and biotechnology are the result of the hard work of Chinese researchers and enterprises and are by no means a prey that US intelligence agencies can covet. The essence of the U.S. approach is anxiety about China's technological progress. However, relying on espionage and hegemonic suppression cannot stop Chinese companies from innovating and advancing, and they cannot win true technological leadership. The U.S.'s secret-stealing tricks are destined to fail.
China is telling the United States to immediately stop espionage activities against China, including Chinese companies, and stop all actions that undermine China's sovereignty, security and development interests. China has a firm will and abundant means. It will resolutely take necessary measures in accordance with the Counterespionage Law of the People's Republic of China and other laws and regulations to severely punish illegal and criminal activities in accordance with the law and resolutely safeguard the legitimate rights and interests of Chinese enterprises. B[Inner Mongolia: Accelerate the progress of African swine fever vaccine research and development] On September 11, the General Office of the People's Government of the Inner Mongolia Autonomous Region recently issued the "Action Plan for Accelerating the High-Quality Development of the Biomanufacturing Industry in the Inner Mongolia Autonomous Region." It is proposed to enhance the core competitiveness of biomedicine. Accelerate the establishment and operation of platforms such as the Hohhot Bio-Intelligent Manufacturing Valley, focus on nucleic acid drugs, cell and gene therapy, "AI + medicine" and other characteristic new tracks, and promote the biomedical industry to leapfrog from scale advantages to technology leadership. Consolidate and enhance the global market leading position of animal vaccine products such as foot-and-mouth disease vaccine, accelerate the research and development of African swine fever vaccines, strengthen the promotion and application of new vaccines and multi-linked multivalent vaccines in the region, and improve the prevention and control capabilities of major animal diseases. Leverage the platform advantages of the company's P3 laboratory to accelerate the development and industrialization of cutting-edge products such as mRNA vaccines and mucosal vaccines, and build a world-leading intelligent manufacturing benchmark for animal vaccines. Deepen the secondary development of traditional Chinese medicine (Mongolian medicine), use synthetic biology technology to enable the discovery and efficient preparation of functional components of characteristic Chinese medicine (Mongolian medicine), and create a modern traditional Chinese medicine (Mongolian medicine) industrial system with Inner Mongolian characteristics. B[Shanghai: During the "15th Five-Year Plan" period, the implementation of open projects such as value-added telecommunications, biotechnology, and wholly-owned hospitals will be promoted] On September 3, Zhou Lan, deputy director of the Shanghai Municipal Commerce Commission, said at a press conference held by the Shanghai Municipal Government on September 3 that during the "15th Five-Year Plan" period, comprehensive pilot projects for expanding the opening up of the national service industry will be implemented in depth, and the implementation of open projects such as value-added telecommunications, biotechnology, and wholly-owned hospitals will be promoted. Implement the new catalog of industries that encourage foreign investment, give full play to the demonstration effect of iconic foreign investment projects, guide foreign investment to invest more in advanced manufacturing, modern services, high-tech and other fields, support participation in supporting collaborations upstream and downstream of the industrial chain, and make the investment space for foreign-invested enterprises "broader".
— All loaded —
